Drug name - Nexiclon Xr
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8337890 | ATHENA | Modified release formulations containing drug-ion exchange resin complexes |
Apr, 2027
(4 years from now) | |
| US8623409 | ATHENA | Clonidine formulation |
Sep, 2031
(8 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 0.17MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| EQ 0.26MG BASE | TABLET, EXTENDED RELEASE;ORAL | Discontinued |
availability in other generic markets.
Click on the highlighted region to filter.